Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts.

The post Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Wall Street Titan: Here’s My #1 Stock for 2023
• It doesn’t matter if you have $500 or $5 million. Do this now.